二甲双胍使用与青光眼患者环视盘视网膜神经纤维层厚度及毛细血管血管密度之间的关联
这项横断面研究纳入346例青光眼疑似或原发性开角型青光眼患者的577只眼,评估二甲双胍使用与环视盘视网膜神经纤维层厚度及全图像毛细血管密度的关联。校正协变量后,二甲双胍使用与更高的全图像毛细血管密度及更厚的环视盘视网膜神经纤维层厚度均存在统计学显著关联。
要点
- 二甲双胍使用与全图像毛细血管密度升高相关(1.56,95%CI 0.40~2.71;p=0.008)。
- 二甲双胍使用与环视盘视网膜神经纤维层厚度增厚相关(5.17 µm,95%CI 1.24~9.10;p=0.010)。
- 二甲双胍使用每延长1年与全图像毛细血管密度升高0.12相关(95%CI 0.02~0.22;p=0.037)。
核心结论
- 二甲双胍使用与更高的全图像毛细血管密度及更厚的环视盘视网膜神经纤维层厚度相关。
- 作者认为这些发现提示一种潜在关联,并强调需要纵向研究来确定二甲双胍是否在青光眼患者的视网膜状况中发挥作用。
研究设计与样本
- 横断面研究,纳入青光眼疑似或原发性开角型青光眼患者,接受光学相干断层扫描血管成像检查。
- 共纳入346例患者的577只眼(330只眼为原发性开角型青光眼,247只眼为青光眼疑似)。
- 在成像时评估抗糖尿病药物的使用及使用时长,采用多变量线性混合效应模型估计糖尿病药物对全图像毛细血管密度和环视盘视网膜神经纤维层厚度的影响。
- 校正协变量包括年龄、种族、体重指数、诊断、24-2视野平均偏差、眼压、平均信号强度指数以及单变量分析中p<0.1的任何变量。
主要发现
- 346例患者中65例(23%)患有糖尿病,其中55例(78.5%)使用二甲双胍,17例(26.2%)使用胰岛素。
- 校正协变量后,二甲双胍使用与全图像毛细血管密度的关联为1.56(95%CI 0.40~2.71;p=0.008)。
- 校正协变量后,二甲双胍使用时长与全图像毛细血管密度的关联为每延长1年0.12(95%CI 0.02~0.22;p=0.037)。
- 校正协变量后,二甲双胍使用与环视盘视网膜神经纤维层厚度的关联为5.17 µm(95%CI 1.24~9.10;p=0.010)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To investigate the association between use of metformin and circumpapillary retinal nerve fibre layer (cpRNFL) thickness, as well as whole image capillary density (wiCD), in patients with glaucoma. METHODS: This cross-sectional study included patients with glaucoma suspect or primary open-angle glaucoma (POAG) underwent optical coherence tomography angiography imaging. Use and duration of antidiabetic medications were assessed at the time of imaging. Multivariable linear mixed-effect modelling was used to estimate the effect of diabetes medication on wiCD and cpRNFL while controlling for covariates including age, race, body mass index, diagnosis, 24-2 visual field mean deviation, and intraocular pressure, average signal strength index as well as any variables that showed a p <0.1 in the univariable analysis. RESULTS: A total of 577 eyes (330 POAG and 247 glaucoma suspect) of 346 patients were included. Sixty-five patients (23%) had diabetes, of whom 55 (78.5%) used metformin, and 17 (26.2%) used insulin. After adjusting for covariates, the association between metformin use and wiCD (1.56 (95% CI 0.40 to 2.71); p=0.008), duration of metformin use and wiCD (0.12 (95% CI 0.02 to 0.22) per 1 year longer; p=0.037), and metformin use and cpRNFL thickness (5.17 (95% CI 1.24 to 9.10) µm; p=0.010) had statistically significant associations in each model. CONCLUSIONS: Metformin use was associated with higher wiCD and thicker cpRNFL. These findings indicate a potential association, underscoring the need for longitudinal studies to determine if metformin plays a role in the retinal conditions of patients with glaucoma. TRIAL REGISTRATION NUMBER: NCT00221897.
引用
- Nishida T, Moghimi S, Gunasegaran G, et al. Association between metformin use with circumpapillary retinal nerve fibre layer thickness and capillary vessel density in glaucoma. Br J Ophthalmol. 2024. PMID: 38839252. doi:10.1136/bjo-2023-325035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。